Abstract:Background Pancreatic angiosarcoma is a rare and highly aggressive tumor originated from lymphatic or vascular endothelial cells with a poor prognosis and few effective treatments. By analyzing the transcriptomic landscape of pancreatic angiosarcoma liver metastasis based on single-cell RNA sequencing, we explored the mechanisms leading to its susceptibility to invasion and metastasis, and tapped into the potential immunotherapeutic targets for the treatment of pancreatic angiosarcoma. Methods One patient diagnosed with pancreatic angiosarcoma with liver metastasis was included in this study. Fresh liver metastasis and adjacent normal liver tissues were processed and single-cell sequenced to obtain single-cell transcriptomic data (IDDF2024-ABS-0238 Figure 1 (A)). We characterized the tumor ecosystem of pancreatic angiosarcoma liver metastasis and compared differences in gene expression and enrichment pathways in cellular subpopulations between tumor region and adjacent normal tissues. The expression level of target genes in mainstream targeted therapy and interactions between individual cell populations were also inspected. Results Pancreatic angiosarcoma cells did not show significantly upregulated expression of targeted therapeutic genes other than CDK4 and EGFR. Up-regulation of proliferation-related pathways including NF-κB, p53, HIF-1 and MYC signaling pathways and cytoskeletal remodeling-related pathways may contribute to the proliferation and metastasis of tumor cells. Several immune checkpoint genes were significantly upregulated in T/NK cells, including CTLA4, LAG3, PDCD1 and CD38, while myeloid cells highly expressed the immune checkpoints CD40, CD86 and LAG3 (IDDF2024-ABS-0238 Figure 1(B)). We found the existence of a markedly immunosuppressive microenvironment in pancreatic angiosarcoma liver metastasis, as evidenced by a significantly lower intensity of cellular interactions between immune cells in the tumor region than in the adjacent normal tissues (IDDF2024-ABS-0238 Figure 1 (C)). The T/NK cell exhaustion and Treg gene set scores were significantly higher in tumor tissues than in adjacent normal tissues, as were the macrophage angiogenesis score and DC cell immunosuppression score (IDDF2024-ABS-0238 Figure 1 (D)). Conclusions In this study, we outlined the presence of an immunosuppressive tumor ecosystem in pancreatic angiosarcoma liver metastasis, suggesting that pancreatic angiosarcoma may be insensitive to most targeted therapies, whereas immunotherapies targeting CD38, LAG3, and PD-L1 (e.g., isatuximab and Opdualag) may be therapeutically effective and worthy of subsequent exploration.

IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells

Antiprogrammed Cell Death Protein 1 Immunotherapy for Angiosarcoma with High Programmed Death-Ligand 1 Expression: a Case Report

IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients

High-Throughput Transcriptomics Identifies Chemoresistance-Associated Gene Expression Signatures in Human Angiosarcoma

RSF1 requires CEBP/β and hSNF2H to promote IL-1β-mediated angiogenesis: the clinical and therapeutic relevance of RSF1 overexpression and amplification in myxofibrosarcomas

miR-497 target gene regulatory network in angiosarcoma

Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum

Interleukin‐1β/nuclear Factor‐κb Signaling Promotes Osteosarcoma Cell Growth Through the Microrna‐181b/phosphatase and Tensin Homolog Axis

Sustained activation of the FGF1-MEK-ERK pathway inhibits proliferation, invasion and migration and enhances radiosensitivity in mouse angiosarcoma cells

Resistin enhances angiogenesis in osteosarcoma via the MAPK signaling pathway

MicroRNA-340 Inhibits the Growth and Invasion of Angiosarcoma Cells by Targeting SIRT7

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Molecular and immune pathobiology of human angiosarcoma

Genomic landscape and preclinical models of angiosarcoma

IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway

Combined VEGFR and MAPK pathway inhibition in angiosarcoma

IDDF2024-ABS-0238 Single-cell Transcriptomic Landscape Indicates the Potential Role of Immunotherapy in Pancreatic Angiosarcoma

IL-13 Receptor Α2 Stimulates Human Glioma Cell Growth and Metastasis Through the Src/PI3K/Akt/mTOR Signaling Pathway.

The Impact and Mechanism of Downregulation of CD13 in Osteosarcoma on Tumor Angiogenesis

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells